Miriam S Komaromy, MD

After a research project engaging people with lived experience of SUD, BMC has findings on making addiction treatment better for Black patients.

The team at BMC's Grayken Center for Addiction is undertaking a major project to answer this question by learning from Black community members.

Data shows that overdose deaths have reached staggering heights. The healthcare system should respond with a person-centered, racial-justice approach.

The low-threshold, transitional housing model aims to help people experiencing homelessness alongside addiction, mental health, and other concerns.

Low-barrier, temporary housing allows people with addiction to stabilize and prepare for transition into permanent housing.

Grayken Center for Addiction staff testified to the state on the need for safe consumption sites to address opioid overdose deaths.

BMC experts testified in support of eliminating the requirement to report abuse and neglect for babies born with neonatal opioid withdrawal syndrome.

Miriam Komaromy, director of BMC's Grayken Center for Addiction cautions that the new rules don't go far enough in addressing opioid overdose deaths.

BMC created a medical unit to provide homeless, COVID-positive patients who were not sick enough to need hospitalization a location to recuperate.

Miriam Komaromy, MD, medical director for the Grayken Center for Addiction at BMC, reacts to the news of increased access to a key medication for OUD.

Pioneering curriculum aims to strengthen inpatient nursing’s role in providing evidence-based care for patients with substance use disorder.

In record time, local and state collaboration stands up respite care for stable COVID-positive people without a safe place to quarantine.